Brief: Glaxosmithkline Pharma March-Quarter Consol Profit Falls
18/05/2021 14:56
May 18 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd
GLAX.NS :
* GLAXOSMITHKLINE PHARMA MARCH-QUARTER CONSOL PROFIT 143.3
MILLION
RUPEES VERSUS PROFIT 1.38 BILLION RUPEES YEAR AGO
* GLAXOSMITHKLINE PHARMA MARCH-QUARTER CONSOL REVENUE FROM
OPERATIONS 8.14 BILLION RUPEES VERSUS 7.76 BILLION RUPEES YEAR
AGO
* GLAXOSMITHKLINE PHARMACEUTICALS LTD - RECOMMENDED DIVIDEND
OF 30
RUPEES PER SHARE
* GLAXOSMITHKLINE PHARMACEUTICALS LTD - RECORDED EXCEPTIONAL
CHARGE OF 1.19 BILLION RUPEES IN THE QUARTER
Source text for Eikon: ID:nBSE9PsbNS
Further company coverage: GLAX.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees